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a b s t r a c t
Anterior cruciate ligament (ACL) reconstruction remains a formidable clinical challenge because of the
lack of vascularization and adequate cell numbers in the joint cavity. In this study, we developed a novel
strategy to mimic the early stage of repair in vivo, which recapitulated extra-articular inflammatory
response to facilitate the early ingrowth of blood vessels and cells. A vascularized ectopic tissue
engineered ligament (ETEL) with silk collagen scaffold was developed and then transferred to reconstruct
the ACL in rabbits without interruption of perfusion. At 2 weeks after ACL reconstruction, more well-
perfused cells and vessels were found in the regenerated ACL with ETEL, which decreased dramatically
at the 4 and 12 week time points with collagen deposition and maturation. ACL treated with ETEL exhib-
ited more mature ligament structure and enhanced ligament-bone healing post-reconstructive surgery at
4 and 12 weeks, as compared with the control group. In addition, the ETEL group was demonstrated to
have higher modulus and stiffness than the control group significantly at 12 weeks post-reconstructive
surgery. In conclusion, our results demonstrated that the ETEL can provide sufficient vascularity and
cellularity during the early stages of healing, and subsequently promote ACL regeneration and
ligament-bone healing, suggesting its clinic use as a promising therapeutic modality.
Statement of Significance
Early inflammatory cell infiltration, tissue and vessels ingrowth were significantly higher in the extra-
articular implanted scaffolds than theses in the joint cavity. By mimicking the early stages of wound
repair, which provided extra-articular inflammatory stimulation to facilitate the early ingrowth of blood
vessels and cells, a vascularized ectopic tissue engineered ligament (ETEL) with silk collagen scaffold was
constructed by subcutaneous implantation for 2 weeks. The fully vascularized TE ligament was then
transferred to rebuild ACL without blood perfusion interruption, and was demonstrated to exhibit
improved ACL regeneration, bone tunnel healing and mechanical properties.
! 2017 Published by Elsevier Ltd on behalf of Acta Materialia Inc.
1. Introduction
As a main stabilizing structure of the knee, the anterior cruciate
ligament (ACL) is one of the most commonly injured ligaments
during sports and other strenuous physical activities [1]. Because
of the unsatisfactory outcomes of conservative treatment modali-
ties, ACL reconstructive surgery is now considered the treatment
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of choice in the majority of clinical cases [2,3]. Despite the draw-
backs of various different types of grafts, such as autograft donor
site morbidity, potential disease transmission with allografts and
the lack of biodegradability of synthetic materials [4,5], the diffi-
culty of achieving revascularization and subsequent delayed liga-
mentization are major obstacles to restoring normal joint
function in the clinic [6–8]. Hence, the regeneration of a functional
ACL, with its dynamic fluid environment and inherent lack of blood
supply and endogenous cells within the joint cavity, is extremely
challenging.
In recent years, tissue engineering (TE) has delivered promising
results that might overcome these challenges [9]. Biological mate-
rials, biodegradable polymers and composite materials have been
developed in ACL reconstruction [9,10]. Amongst these, silk-
based biomaterials have been intensively studied, due to their
good biocompatibility, mechanical strength and controllable
biodegradability [11]. To date, silk-based biomaterials have
achieved promising results in the repair of injured Achilles tendon
[12], medial collateral ligament (MCL) [13] and shoulder rotator
cuff tendon [14]. Based on the promising outcomes of extra-
articular tendon/ligament regeneration, the silk scaffold was also
applied in ACL reconstruction in rabbits and there was observed
to be functional ACL regeneration and osteoarthritis (OA) improve-
ment in the long term [15]. However, the lack of inflammatory
response, vascularization and adequate cell numbers during the
early stage of ACL regeneration, which leads to a prolonged regen-
erative process and lack of mechanical support during the early
stage, still present an exigent issue to be resolved.
Vascularization is a key process in tissue engineering, particu-
larly for massive tissue repair of the avascular environment of a
host site like ACL [16,17]. Various attempts have been made to
generate a functional vasculature in recent years, including bio-
chemical modification [18–21], exogenous cells [10,22–24], and
microengineering technology [25–30]. Most of these attempts,
however, have only focused on applying exogenous vascular cells
and angiogenic factors. Recently, the fundamentals of the proper
endogenous immune system response in vascular formation and
adaptation is being increasingly recognized [31–33]. Many types
of immune cells have been demonstrated to function in early vas-
cular formation. Amongst these, macrophages have been inten-
sively studied and are thought to be one of the most important
cell types involved in this process, because it can produce and
secrete various bioactive molecules, including vascular endothelial
growth factor (VEGF), transforming growth factor-beta (TGF-b),
basic fibroblast growth factor (bFGF), platelet derived growth
factor-BB (PDGF-BB), tumor necrosis factor (TNF), and various
cytokines of the Interleukin (IL) family such as IL-6, IL-10 and IL-
17 [34–37]. These factors play critical roles in controlling neovas-
cularization and vascular remodeling, as well as the regenerative
response by promoting tissue-endogenous adult stem cell prolifer-
ation [37,38]. Depletion of macrophages have been proven to be
detrimental to vascular formation and wound healing [39,40].
Hence, the recapitulation of a proper early inflammatory response
and endogenous repair processes, particularly macrophage recruit-
ment and activation, may be an effective strategy to enhance vas-
cularization in tissue engineering.
In this study, we demonstrated that early inflammatory cell
infiltration and angiogenic factor gene expression were signifi-
cantly higher in the subcutaneously implanted silk collagen scaf-
folds than the intra-articular implanted scaffolds, which was
correlated with faster and better vascularization and tissue
ingrowth. Hence, we developed a new strategy to mimic the early
stages of wound repair, which provided extra-articular inflamma-
tory stimulation to facilitate the early ingrowth of blood vessels
and cells. A vascularized ectopic tissue engineered ligament (ETEL)
with silk collagen scaffold was constructed by subcutaneous
implantation for 2 weeks. The fully vascularized TE ligament was
then transferred with one end free, as a flap, to rebuild the ACL
in rabbits without interruption of blood perfusion. ACL regenera-
tion, ligament-bone integration and mechanical properties were
subsequently evaluated.
2. Materials and methods
2.1. Scaffold fabrication
Raw silk fibers (Bombyx mori) were purchased from Zhejiang
Cathaya International Inc. (Hangzhou, China). The silk collagen
sponge scaffold was fabricated as described previously [13]. Briefly,
the knitted silk was fabricated using 19 yarns (1 filament/yarn) of
silk fibers on a knitting machine. The pore size was approximate
0.4 ⁄ 0.4 mm. The knitted silks were treated with an aqueous solu-
tion containing 0.02 M Na2CO3 at 90 "C and 100 "C for 60 min to
extract the sericin. Insoluble type I collagen was isolated and puri-
fied from pig Achilles’ tendon using neutral salt and dilute acid
extractions as described previously [41]. Briefly, pig Achilles’s ten-
don was separated, cut into pieces and washed, followed by incu-
bation in 0.5 M acetic acid (HAc) (pH 2.5) at 4 "C for 16 h. Then the
tendon was briefly homogenized and subjected to centrifugation at
22,000g at 4 "C for 15 min. Stepwise extraction of collagen was car-
ried out, followed by washing in 0.1 M NaCl, 0.05 M Tris—HCl (pH
7.2) with 20 mM ethylene diamine tetra acetic acid (EDTA) and
2 mM N-ethylmaleimide (NEM) for 3 days, 1.0 M NaCl, 0.05 M
Tris—HCl (pH 7.2)with 20 mM EDTA and 2 mM NEM for 5 days,
0.5 M HAc (pH 2.5) with 4 M urea and 2 mM NEM for 1 day,
0.5 M HAc (pH 2.5) with 2 mM NEM for 3 days, demineralized
water for 2 days, acetone for 4 days and finally water for the last
3 days. For all steps, the buffer was changed daily and centrifuga-
tion at 22,000g (4 "C) for 15 min was performed to recover the col-
lagen. All reagents used above were purchased from Sigma-Aldrich
(St. Louis, MO, USA). Purified collagen was lyophilized afterwards.
The sericin-extracted knitted silk mesh (Fig. S1A) was immersed in
an acidic collagen solution (type I, pH 3.2, 1 wt%, 3 mm depth), and
frozen at 80 "C for 12 h. It was then freeze-dried under vacuum
(Heto PowerDry LL1500) for 48 h to allow the formation of colla-
gen sponges. Then the scaffolds were cross-linked by dehydrother-
mal treatment and cut into two different sizes at 0.5 cm ⁄ 0.5 cm
for the first stage animal experiments and 1 cm ⁄ 8 cm for the sec-
ond stage animal experiments (see below) (Fig. S1B).
The ‘‘sandwich-like” structure of the scaffold, with knitted silk
incorporated between two layers of collagen sponge, was demon-
strated by a scanning electron microscope (SEM). (Fig. S1C) To
accomplish the SEM test, the specimens were dehydrated in
increasing concentrations of alcohol (30% to 100% v/v) and were
critically point-dried. These were then mounted on aluminum
stubs and coated with gold, and viewed under a Hitachi S-3000 N
SEM at an accelerating voltage of 15 kV.
2.2. Animal experiment
Forty-eight New Zealand White rabbits weighing 2.5–3.0 kg
were utilized for this study. The animals were subjected to general
anesthesia, skin preparation and disinfection according to standard
surgical protocols. Two stages of animal experiments were carried
out in this study.
In the first stage, subcutaneous and intra-articular environment
were compared. Twenty-four rabbits were used in this stage. The
knitted silk collagen scaffolds were immersed in sterile phosphate
buffered solution (PBS) before implantation. Anterior midline skin
incision and lateral parapatellar arthrotomy [42] were used to
expose the subcutaneous cavity and to open the knee joint cavity
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in one leg respectively. The scaffolds were then implanted subcu-
taneously and intra-articularly. The incision was sutured layer by
layer up to the skin surface. At 3 days, 1, 2 and 4 weeks after
implantation, the animals were sacrificed and the scaffolds were
explanted for further evaluation.
In the second stage, ACL reconstruction was conducted to com-
pare the effect of ETEL and silk collagen scaffold in the rest twenty-
four rabbits. Subcutaneous implantation was performed in a simi-
lar procedure above, with one side tightly ligated to the lower part
of the patellar ligament and the other side anchored to the subcu-
taneous fascia in the left leg. Two weeks after implantation, the
scaffold was carefully separated from the distal end with the prox-
imal end reserved. Lateral parapatellar arthrotomy was used to
expose the knee joint of the rabbit. After the native ACL excision,
the tibial and femoral bone tunnels were created with a 3.0 mm
diameter drill-bit. The vascularized ETEL was carefully pulled
trough the bone tunnel and fixed with 2-0 polyester suture
(MERSILK, Johnson & Johnson, US) in a whipstitch style. For the
control group, the simple silk collagen scaffold was rolled up along
the short axis and passed through the tunnel with both ends fixed.
The incision was then closed layer by layer up to the skin. After
surgery, animals were allowed free cage activity. Upon animal sac-
rifice, three limbs from each experimental group were utilized for
histological evaluation and gene expression analysis at the 2, 4 and
12 weeks time points, 3 additional limbs from each group were
subjected to mechanical test at 12 weeks. Specimens were imaged
by transmission electron microscopy (TEM) to assess the collagen
fibril diameter after 2, 4 and 12 weeks post-surgery, and were
scanned with MRI and microCT at the 12 weeks time point. Treat-
ment of animals was in accordance with standard guidelines
approved by the Ethics Committee of the second affiliated hospital,
school of medicine, Zhejiang university (Ethical approval number:
2015-401).
2.3. Macroscopic and histological assessment
Specimens were fixed with 4% paraformaldehyde, decalcified
with 10% EDTA, gradiently dehydrated, and embedded within
paraffin blocks. Histological sections (7 mm) were prepared using
a microtome, and subsequently deparaffinized with xylene,
hydrated using decreasing concentrations of ethanol, and then
subjected to hematoxylin and eosin (HE) staining, Masson
trichrome and safranin O (SO) staining. Histological scoring of
ACL repair was performed by two people using a blinded semi-
quantitative scoring system based on six parameters (fiber
structure, fiber arrangement, rounding of nuclei, vascularity,
inflammation, cell population) of HE staining. Every parameter
was graded from 0 to 3, with 0 being normal and 3 being maxi-
mally abnormal [43].
2.4. Collagen content assay
The amount of deposited collagen on the scaffold was quanti-
fied by using a collagen quantitative assay kit (Jiancheng Inc.,
Nanjing, China) following the manufacturer’s protocol [13].
2.5. RNA isolation and real time polymerase chain reaction (RT-PCR)
Total tissue RNA was isolated by lysis in TRIZOL (Invitrogen Inc.,
Carlsbad, CA, USA) followed by a one-step phenol chloro-
formeisoamyl alcohol extraction as described by the manufac-
turer’s protocol. Real-time PCR analysis of seven genes including
CD86, ARGINASE-1 (ARG-1), vascular endothelial growth factor
(VEGF), COLLAGEN I (COL I), TENASCIN (TNC), COLLAGEN III (COL
III) and GAPDH was performed using Brilliant SYBR Green QPCR
Master Mix (TakaRa) with a Light Cycler apparatus (ABI STEPONE
PLUS), as described previously [44]. The primer sequences used
in this study are listed in Table 1. Each real-time PCR run was per-
formed with at least three experimental replicates, and the results
are presented as target gene expression normalized to GAPDH.
2.6. Immunohistochemistry
A series of 7 mm-thick sections were utilized for immunohisto-
chemical staining (IHC). Endogenous peroxidase was firstly
blocked with hydrogen peroxide before pepsin treatment for
20 min. Mouse anti-rabbit monoclonal antibodies against
a-smooth muscle actin (a-SMA) (1:200 dilution; BOSTER Inc.,
Wuhan, China) and CD14 (1:200 dilution; BOSTER Inc., Wuhan,
China) were used to detect the presence of blood vessels and
inflammatory cell infiltration in the subcutaneously implanted
scaffold and the repaired ACL respectively. Monoclonal antibodies
were applied for 1 h followed by incubation with biotinylated goat
anti-mouse antibody (Lab Vision Corporation, CA) for 30 min.
Streptavidin peroxidase was added for 45 min and 3,30-
diaminobenzidine was used as a chromogenic agent.
2.7. Transmission electron microscopy (TEM)
Tissue specimens at the 2- and 12-weeks time points from each
group were fixed following the standard procedures for TEM to
assess collagen fibril diameter within the regenerated ACL. Speci-
mens were pre-fixed with 2% glutaraldehyde for 24 h and washed
twice with PBS followed by post-fixation treatment with 1% osmic
acid for 2 h. After two washes in PBS, the specimens were dehy-
drated in ethanol gradient (50%, 70%, 80%, 90%, and 3 changes of
100%). Propylene oxide was used as a transitional solvent. The
specimens were infiltrated in a 1:2 mixture of EponAraldite
embedding resin and propylene oxide for 24 h, followed by a 1:1
mixture of resin and propylene oxide for 24 h, and a 2:1 mixture
of resin and propylene oxide. Finally, the specimens were infil-
trated in 100% Epon-Araldite using molds for 48 h at 60 "C. The
embedded specimens were thin sectioned (70 nm) and viewed
under TEM (Quanta 10 FEI). Approximately 500 collagen fibrils
were imaged and measured for each sample to obtain an accurate
representation of the fibril diameter distribution, using image anal-
ysis software (Image-Pro Plus, Rockville, MD, USA).
2.8. MicroCT
For microCT observations, specimens were first fixed with 4%
(w/v) paraformaldehyde for 2 days. Subsequently, specimens from
each group (12 weeks) were scanned with a MicroCT imaging
system with an 18 mm isotropic voxel resolution under 60 kV
scanning voltage (Skyscan1076, Micro Technology, Hong Kong).
2.9. Magnetic resonance imaging (MRI)
Before MRI analysis, the rabbits were subjected to general
anesthesia at 12 weeks post-reconstruction. The MRI images were
acquired by a 3.0T MRI imaging system (Siemens, Germany), with
the parameters being set and the process being conducted by an
experienced engineer. T2 phase (or T2-weighted imaging, T2WI)
was used to assess the bone tunnel healing and articular
fluid distribution. The parameters were set as follows: repetition
time (TR) = 3000 ms, echo time (TE) = 100 ms, scanning slice
thickness = 2 mm.
2.10. Mechanical evaluation
Mechanical testing was performed using an Instron tension/
compression system with Fast-Track software (Model 5543,
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Instron, Canton, MA). For ACLs, both hindlimbs were disarticulated
at the hip joint, wrapped in saline-soaked gauze, immediately
packed in plastic bags, and stored at !20 "C. Before biomechanical
testing, the frozen, saline-soaked specimens were thawed at room
temperature. The ACLs were prepared with attached femoral and
tibial bone blocks, leaving the insertion sites intact. The specimens
were then dissected free of all soft tissue except the ACL, leaving a
femur–ACL–tibia complex (FATC).
The FATCs were then rigidly fixed to custom-made clamps to
align the collagen fibers. After applying a pre-load of 3 N, each
FATC underwent pre-conditioning by cyclic elongation between 0
and 0.75 mm for 3 cycles at 5 mm/min. This was followed by load
to failure testing at an elongation rate of 5 mm/min. The load–
elongation behavior of the FATCs and failure modes were recorded.
The structural properties of the FATC were represented by stiffness
(N/mm), maximal load (N) and modulus (MPa).
2.11. Statistical analysis
All quantitative data sets are expressed as mean ± SD. Student’s
t-test was performed to assess statistically significant differences
in the results of different experimental groups. All statistical data
were analyzed by the IBM SPSS Statistics software 19.0. Values of
p < 0.05 were considered to be significantly different.
3. Results
3.1. Subcutaneous implantation of SCSs enhanced vascularization and
promoted more cell and tissue ingrowth than intra-articular
implantation, which correlates with increased infiltration of CD14
positive cells and inflammatory response
To compare the early inflammatory response between the sub-
cutaneous and intra-articular microenvironment during tissue
engineering, we first implanted the silk collagen scaffolds within
the rabbit subcutaneous pocket and knee joint cavity for up to
4 weeks. HE staining demonstrated that cellular and neo-tissue
ingrowth was slow in the intra-articular scaffolds. In contrast,
however, large numbers of cells and abundant matrix deposition
were found in the subcutaneous scaffolds at 1 week post implanta-
tion. (Fig. 1A, D). The expression of extracellular matrix (ECM)
related genes such as col 1 was also significantly higher in the
subcutaneous group at 1 week post-implantation (Fig. 1J).
Immunohistochemical (IHC) staining revealed that CD14 positive
monocyte/macrophage infiltration inside the scaffold was signifi-
cantly higher in the subcutaneous group, compared with the
intra-articular group. (Fig. 1B, red arrow; E) As there are few anti-
bodies available to distinguish the macrophage subtypes of rabbits,
RT-PCR analysis of CD86 and arginase 1 (ARG-1) gene expression
was chosen as an alternative to detect M1 and M2 macrophages,
respectively. The RT-PCR result showed higher expression of
CD86 genes in the subcutaneous group, as compared to the intra-
articular group at day 3, week 1 and week 2 post-reconstruction
(Fig. 1G). The expression level of ARG-1, however, was not
significantly different between the two groups in all time points
(Fig. 1H). Furthermore, the pro-angiogenic factor VEGF, which
was thought to be mainly produced by macrophages, was also
detected by RT-PCR and resulted in significantly higher expression
in the subcutaneous group at 1 week post-implantation (Fig. 1I).
Finally, the blood vessel density was demonstrated to be signifi-
cantly higher in the subcutaneously implanted scaffold by IHC
staining against a-SMA (Fig. 1C, F). Hence, we demonstrated that
the inflammatory response profile in the joint cavity was
apparently different from that subcutaneously, which was corre-
lated with significantly lesser neo-tissue ingrowth and slower
regeneration.
3.2. Ectopic tissue engineered ligament (ETEL) was constructed by
subcutaneous implantation of silk-collagen scaffolds for 2 weeks
before further ACL reconstruction
Based on the aforementioned previous results, we hypothesized
that ectopic implantation of the silk collagen scaffold in the subcu-
taneous pocket could mimic the early stages of repair and develop
a highly vascularized and multicellular tissue engineered ligament,
which could be grafted to surgically reconstruct the ACL without
interruption of perfusion by the flap technique. Since there was
more cellularity and vascularity at the 2 weeks timepoint
(Fig. 1A–E, G), subcutaneous implantation of the silk-collagen scaf-
folds for 2 weeks was chosen to develop the highly vascularized
ectopic-engineered ligament.
After two-weeks post subcutaneous implantation, the ectopic
tissue engineered ligament showed a pink appearance with rich
blood supply, which was carefully separated from the distal end
while the proximal end was retained and the adjacent vascular
network connection was fully protected (Fig. 2Ab, Bb arrow). After
opening the joint cavity, the native ACL was completely removed
and a bone tunnel was drilled into the tibia and femur (Fig. 2Ac,
Bc). Then the distal end of the ETEL was pulled through the bone
tunnel gently and fixed (Fig. 2Ad, Bd). In the control group, a sim-
ple silk collagen scaffold without subcutaneous implantation was
used to reconstruct the ACL by a similar procedure (Fig. 2Ae, Be).
At 2, 4 and 12 weeks after ACL reconstruction, the animals were
sacrificed for further evaluation (Fig. 2C).
3.3. ETEL promoted ACL regeneration with better tendinous properties
No necrotic or inflammatory tissue was found at all time-points
in the ETEL group, thus indicating that the blood flow in the graft
was patent without obvious obstruction (Fig. 3A, B). Gross mor-
phology revealed that the ETEL was covered with regenerated
fibrous tissues and the silk fibers could not be clearly discerned
at all time-points. By contrast, less fibrous tissue ingrowth was
observed in the SCS group, which resulted in a fuzzy appearance.
(Fig3A)
The histology of the ETEL groups showed that denser connective
tissues filled and wrapped the scaffold (Fig. 3B). At 2 weeks
post-implantation, abundant blood vessels and spindle tendon-
like cells were present within the regenerated tissues around the
scaffold in the ETEL group, whereas there were few cells or
angiogenesis in the SCS group (Fig. 3B, D). At 4 and 12 weeks
post-reconstruction, the blood vessel and cell numbers decreased
gradually in the ETEL group, along with the elongation of
tendon-like cells and increased ECM deposition. The SCS group,
however, exhibited insufficient repair tissues with the absence of
repair at some sites, although the cell numbers and blood vessels
increased at 4 and 12 weeks post-reconstruction (Fig. 3B, D, E, F).
Additionally, the histological score of the ETEL group was signifi-
cantly lower than the SCS group at all time-points, indicating
improved regeneration of the ACL (Fig. 3G).
Table 1
Primer sequences of selected genes utilized in this study for RT-PCR.
Gene Name Forward Primer Reverse Primer
GAPDH TCACCATCTTCCAGGAGCGA CACAATGCCGAAGTGGTCGT
CD86 CAGATCAAGGACAAGGGCGT CCTTGTACAGACGAGCAGGT
ARG-1 GCTGTCATTTGGGTGGATGC CCTTGGCAGATATGCAGGGA
VEGF ACCGAGGAGTTCAACGTCAC AGCTCATCTCCCCTATGTGC
Col 1a1 CGATGGCTTCCAGTTCGAGT GCTACGCTGTTCTTGCAGTG
Col 3a1 GTTCTGGAGGATGGCTGCTC TCACAGCCTTGCGTGTTCTA
TNC CATCCGGCACAAACGACAG CATCCGGCACAAACGACAG
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Fig. 1. Comparison of inflammatory response and neo-tissue ingrowth in the silk collagen scaffold between intra- and extra-articular implantation. (A) HE staining; (B–C) IHC
staining against CD14 and a-SMA, respectively. Red arrow: CD14 positive cells; Black arrow: blood vessels. (D–F) Quantification of total cells, CD14 positive cells and blood
vessels in each high power field. (G–J) RT-PCR analysis of CD86, ARG-1, VEGF and Col 1. *: p < 0.05. Scale bar = 50 mm, 200 mm (inset). Abbreviations: a-SMA: alpha smooth
muscle actin; HPF: High-power field. ARG-1: arginase 1; VEGF: vascular endothelial growth factor; Col 1: collagen type 1.
Fig. 2. Schematic diagram of ectopic tissue engineered ligament development and ACL reconstruction. Schematic diagram (A) and gross morphology (B) of scaffold
vascularization and the ACL reconstruction procedure: (a) Silk collagen scaffolds (SCS) were implanted subcutaneously around the knee joint. Dotted line: Edge of the silk
collagen scaffold. (b) 2 weeks after subcutaneous implantation, the ectopic tissue engineered ligament (ETEL) were developed (red in A.a). Black arrow: Neovascularization
derived from adjacent tissue. (c) Native ACL (Bc, left panel, green arrow) was removed (Bc, right panel), without injury of posterior cruciate ligament (yellow arrow). Bone
tunnel was then made by drilling. (d) The ETEL was transferred for ACL reconstruction without blockage of blood vessels. (e) Simple silk collagen scaffold was used as a
control for ACL reconstruction with similar surgical procedure. (C) Time points of the experiment. Abbreviations: P: Patella. QF: Quadriceps femoris. PT: Patellar tendon. F:
Femur condyle. T: Tibia. BT: Bone tunnel. L: Lateral side. M: Medial side. SCS: Silk collagen scaffold. ETEL: Ectopic tissue engineered ligament. ACL: Anterior cruciate ligament.
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Masson trichrome staining showed that in the ETEL group, the
collagen content increased and the collagen fiber arrangement
was aligned in a parallel manner, indicating collagen maturation
with prolonged duration. In contrast, in the SCS group, collagen
deposition was less than the ETEL group at all time-points
(Fig. 3C). Further quantitative analysis demonstrated that the ETEL
group promoted more collagen deposition than the SCS group at all
time-points (Fig. 3K). Additionally, gene expression levels of liga-
ment repair markers including Col I, Col III, and TNC was higher
than the SCS group at early stages (Fig. 3H–J).
3.4. ETEL enhanced collagen fibril formation and maturation
The reconstruction and maturation of regenerated ACL are evi-
dent by the formation of collagen fibrils. Hence, we evaluated col-
lagen fibril formation with polarized light microscopy (Fig. 4) and
transmission electron microscopy (TEM) (Fig. 5). In the SCS group,
only a few dispersed fibrils could be observed under polarized light
microscopy at 12 weeks post-reconstruction (Fig. 4A, C, E, white
arrow). In contrast, in the ETEL group, collagen fibrils could be
detected at 2 weeks post-reconstruction and became more contin-
uous and transparent at 4 weeks and 12 weeks post-reconstruction
(Fig. 4B, D, F, red arrow).
TEM imaging from the cross-section revealed denser and larger
fibril formation in the ETEL group, as compared to the patched,
sparse and thin fibrils observed in the SCS group (Fig. 5A). In longi-
tudinal section TEM imaging, collagen fibrils were observed to be
more organized and compact in the ETEL group compared to the
SCS group at all time points (Fig. 5B). In the ETEL group, the distri-
bution of collagen fibrils exhibited a dramatic remodeling process,
which exhibited a large-small pattern in 2 weeks resulting from
the newly-formed fibril production, and which turned into a
homogeneous pattern in 12 weeks with new fibrils growing stron-
ger (Fig. 5A,E, F). In contrast, the fibril distribution of the SCS group
presented a classic regenerative pattern with increased collagen
fibril diameter and density as time progresses (Fig. 5A, C, D). Addi-
tionally, the quantification analysis demonstrated a significantly
lager fibril diameter in the ETEL group, as compared to the SCS
group at week 2 and 12 (Fig. 5G).
3.5. ETEL enhanced ligament-bone integration
Besides ACL regeneration, we also evaluated the effects of the
ETEL on ligament-bone junction regeneration. At 2 weeks post-
reconstruction, more fibrous connective tissue was present
between the host bone and the scaffold in the ETEL group, as
compared to the SCS group (Fig. 6 A, Fig. S2A). At 4 and 12 weeks
post-reconstruction, a typical ligament-bone interface with the
integration of fibrocartilage layers was generated in the ETEL group
(Fig. 6 B&C, black arrow; Fig. S2 B&C), whereas no fibro-
cartilaginous tissue was formed in the SCS group. In the SCS group,
the MRI analysis revealed a high signal gap around the scaffold in
the T2 phase at 12 weeks post-reconstruction (Fig. 6D&E, red
arrow), indicating a poor union of the scaffold with the bone tissue.
On the reverse, no obvious gap was detected between the ETEL and
the host bone. In the microCT analysis, more mineralized tissue
Fig. 3. ACL regeneration at 2, 4, and 12 weeks post-reconstruction with ETEL and simple silk collagen scaffold. (A) Gross morphology of the regenerated ACL. (B) HE staining
images. (C) Masson Trichrome staining images. (D) IHC against a-SMA. Arrow: blood vessels. (E–F) Quantification of blood vessels and cells in each high power field. (G)
Histological evaluation. (H-J) RT-PCR analysis of tendon-associated genes collagen I (COL I), collagen III (COL III) and tenascin (TNC). (K) Collagen content analysis.
Abbreviations: a-SMA: a smooth muscle actin. HPF: High-power field. SCS: Silk collagen scaffold. ETEL: Ectopic tissue engineered ligament. *: p < 0.05. Scale bar = 50 mm,
200 mm (inset).
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Fig. 4. Polarized light microscopy images at 2 (A–B), 4 (C–D) and 12 weeks (E–F) post-ACL reconstruction. Scale bar = 500 mm (A–F), 100 mm (a–f). SCS: Silk collagen scaffold.
White and red arrows: Mature collagen fibers. Abbreviations: SCS: Silk collagen scaffold. ETEL: Ectopic tissue engineered ligament.
Fig. 5. Evaluation of collagen fibril formation at 2 and 12 weeks post-reconstruction. (A) TEM images of cross-section. Scale bars = 0.2 mm (Top panels of cross-section),
100 nm (bottom panels of cross-section). (B) TEM images of longitudinal section. Scale bars = 0.5 mm. (C–F) Distribution of collagen fibril diameters. (G) Average collagen fibril
diameter. *: P < 0.05. Abbreviations: SCS: Silk collagen scaffold. ETEL: Ectopic tissue engineered ligament.
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was found in the bone tunnel of the ETEL group, as compared to the
SCS group (Fig. 6F).
3.6. ETEL exhibited better mechanical properties
The mechanical test were also carried out to evaluate the func-
tion of ACL regeneration at 12 weeks post regenerative surgery. As
illustrated in Fig. 7A, the load-elongation curves were tall and
steep in the ETEL group whereas those were laigh and elongated
in the SCS group. The stiffness and modulus were significantly
higher in the ETEL group than the SCS group (21.60 ± 7.30 vs.
7.02 ± 1.93 N/mm and 49.49 ± 10.14 vs. 17.12 ± 1.89 MPa, respec-
tively; n = 3, p < 0.05 for both) (Fig. 7B). The maximal load of regen-
erated ACL in ETEL group were 78.3% higher than that in the SCS
group, but the difference was not significant. This may due to the
relatively small sample size (n = 3).
4. Discussion
Surgical reconstruction of a functional ACL after injury remains
a formidable clinical challenge. In this study, we created a new
ETEL based on our previous study. ETEL overcame the lack of initial
inflammatory response and cellularity within the joint cavity and
promoted ACL regeneration with more ECM deposition, enhanced
collagen fibril maturation, larger collagen fibril diameters and
increased expression of ligament-associated genes, as well as
improved ligament-bone healing and mechanical properties.
Hence, it is evident that the vascularized ETEL is a promising bio-
material construct for ligament tissue engineering and clinical
treatment of ACL injuries.
It is well-known that the regenerative process of the intra-
articular ACL is markedly prolonged compared to MCL [13,15].
The differences in microenvironment and inflammatory response
maybe a major reason for the different early regenerative out-
comes of ACL versus MCL. The inflammatory response after ACL
injury was demonstrated to be relatively mild compared to MCL
injury, as evidenced by an absence of wound site filling, paucity
of inflammatory cells and dramatically decreased presence of
important extracellular matrix proteins and cytokines within the
ACL wound site [45–47]. In accordance with the histological results
of ACL injury, in this present study, we demonstrated that the early
inflammatory response during scaffold based tissue engineering
was also markedly different between the intra- and extra-
articular microenvironment. CD14 positive monocytes/macrophages
recruitment, pro-angiogenic factor VEGF gene expression,
vascularization and neo-tissue ingrowth in the subcutaneously
implanted scaffolds were far greater than the intra-articular
scaffold (Fig. 1). Hence, based on this finding, we further
developed a novel strategy to avoid the poor early inflammatory
response in the intra-articular environment and accelerate the
early ingrowth of endogenous cells and micro vessels into the
silk collagen scaffold by preliminarily implanting the silk
collagen scaffold in an ectopic subcutaneous pocket. After
transferring the ectopic tissue engineered ligament into the joint
cavity for ACL reconstruction, abundant well-perfused cells were
preserved within the scaffold, which gradually decreased in
number in the intra-articular environment with ligament
maturation.
Autografts and allografts are the most common graft types
utilized to surgically reconstruct ACL at present. The healing
procedure with grafting has been demonstrated by in vivo and
in vitro studies to have three characteristic stages: an early graft
healing phase with central graft necrosis, hypocellularity with no
detectable revascularization, followed by a highly intensive revas-
cularization and remodeling phase with cell infiltration and prolif-
eration, and finally a ligamentization phase with characteristic
remodeling of the graft towards the properties of intact ACL [48].
Although normal tendon/ligaments exhibit an avascular or hypo-
vascular structure and neovascularization is always related to
tendinopathy or injuries, revascularization is a key process to
initiate cell ingrowth and matrix remodeling during ACL
reconstruction. The remnant preserving technique, which provides
more blood vessels and proprioceptive tissues, is demonstrated to
result in increased ligamentization, ligament-bone integration and
Fig. 6. Assessment of regenerative ligament-bone integration. Safranin O staining
images at 2 (A), 4 (B) and 12 weeks post-reconstruction. Scale bars = 200 mm,
500 mm (inset). (C). Black arrow: cartilage formation. (D-E) MRI images from the
vertical plane (D) and horizontal plane (E) in the T2 phase for samples at 12 weeks
post-reconstruction. Dotted curve: Outer line of femur condyle. White star:
regenerative scaffold. Red arrow: High signal was present around the scaffold,
indicating a gap filled full with joint fluid. (E) Reconstructed image of microCT
analysis for samples at 12 weeks post-operation. Abbreviations: SCS: Silk collagen
scaffold. ETEL: Ectopic tissue engineered ligament. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of
this article.)
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mechanical strength in animals [49–51]. By contrast, the delay or
failure of vascularization is always associated with bad ligament-
bone healing and insufficient ligament maturation, which may
result in reconstruction failure as manifested by graft rupture
and joint laxity [52,53].
Adequate vascularization is also essential for tendon/ligament
development, repair and regeneration. During development, ten-
dons are highly plastic tissues in fetus with high cellularity and
vascularity, which decrease with tendon maturation [54,55].
Although over-expression of vascular endothelial growth factor
(VEGF) has been shown to impede improvements in biomechanical
strength after ACL regeneration, blocking VEGF significantly
reduced angiogenesis, graft maturation and biomechanical
strength [56]. Despite a supportive role in delivering oxygen and
nutrients, the perivascular cells have been demonstrated to play
an important role in contributing to mesoderm tissue growth
and repair but will result in pathological fibrosis if over-
stimulated [57–60]. These previous studies emphasized the
requirement for proper dynamic vascularity during ACL regenera-
tion. In this study, we developed a highly vascularized and cellular
plastic scaffold, which exhibited reduction in cell numbers and
blood vessels after being implanted for ACL reconstruction, which
mimicked the natural tendon development process and resulted in
a hypovascular structure with parallel cells and fibers within
12 weeks. The characteristics of the regenerated ACL, including
gross morphology, cell shape, ECM accumulation and collagen
microstructure were more similar to native ACL in the ETEL group
than the SCS group, which contributed to better biomechanical
properties in the ETEL group. Although the mechanism of the vas-
cular decrease is not clear, the mechanically-induced downregula-
tion of VEGF expression may be a possible reason [61].
Besides ACL regeneration per se, the ligament-bone integration
is also important for effective ACL reconstruction, by enabling ear-
lier and robust rehabilitation and to prevent long-term OA occur-
rence due to ligament tear or joint laxity. Firm ligament-bone
integration can be achieved by the direct osteointegration of the
tendon graft, which resembles the normal chondral entities of
ACL and which has been proven to be biomechanically stronger
than the indirect connection by Sharpey-like collagen fibers [62].
To enhance this process, a variety of bioactive techniques have
been developed, consisting mainly of growth factor release and
stem cell transplantation. A number of growth factors with
osteoinductive activity, such as bone morphogenetic proteins
(BMPs) [63,64] and transforming growth factors (TGF) [65], have
been applied to enhance ligament-bone integration and result in
more favorable outcomes. Additionally, the pro-angiogenic fator
VEGF, which can synergize with BMP2 to promote bone formation
and bone healing via modulation of angiogenesis [66,67], can also
promote ACL-bone integration as well [68]. On the other hand,
bone marrow mesenchymal stem cells (MSCs), with their ability
to differentiate into muscle, tendon, cartilage and bone, have also
been widely used to augment ligament bone healing [69,70].
Besides MSCs, blood vessels also have a rich supply of stem/
progenitor cells that display characteristic expression of CD34 sur-
face markers [71,72]. Human ACL-derived CD34+ cells have been
demonstrated to contribute to tendon-bone healing after ACL
reconstruction in a rat model [73]. In this study, high expression
levels of the angiogenesis-associated factor VEGF coupled with
the presence of multi-potential regenerative cells maybe the rea-
sons for the enhanced formation of fibrocartilage and mineralized
bone formation within the bone tunnel.
Our study thus provided a step-wise strategy for ACL recon-
struction with a self-assembly phase to generate a vascularized
TE ligament before reconstructive surgery. This strategy con-
tributed to efficacious ligament regeneration and ligament-bone
healing, thus indicating promising potential for clinical translation.
The patients themselves can be employed as a ‘‘physiological
incubator” and the generated ectopic TE ligament contains autolo-
gous regenerative cells within a neo-vascularized and highly-
biocompatible silk collagen scaffold. This scaffold based procedure
negates the requirement for autologous, allogeneic and xenogenic
ligament grafts, thus avoiding the risk of disease transmission and
donor site morbidity. However, the requirement for two surgical
procedures, which may increase patients’ discomfort and medical
costs, are the key drawbacks of its clinical translation.
Nevertheless, there are still some limitations to our study. We
used rabbits as a proof-of-concept model which may not fully
mimic human physiological and mechanical conditions. The lim-
ited number of experimental animals may not represent enough
evidence, too. Big animal models, such as pig and sheep, may be
needed for further evaluation before the onset of clinical trials.
5. Conclusion
In summary, this study developed a vascularized ectopic tissue
engineered ligament with silk collagen scaffold. The tissue engi-
neered ligament not only enhanced ACL regeneration, but also
promoted ligament-bone healing and offered better mechanical
properties. This result highlights the importance of sufficient
early-stage perfusion and cells in ACL regeneration. Our work thus
provide valuable insight for future ligament tissue engineering
studies and clinical practice.
Fig. 7. Mechanical test of regenerated ACL at 12 weeks post surgery. (A) Load-elongation curve of mechanical test in ETEL and SCS group (n = 3). Black triangle indicated the
maximal load site. (B) Statistic compare of maximal load, modulus and stiffness between ETEL and SCS group. *: p < 0.05. Abbreviations: SCS: Silk collagen scaffold. ETEL:
Ectopic tissue engineered ligament.
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